Zimbabwe has declined a major American healthcare agreement valued at 367 million US dollars (£272m) over five years over Washington's demand for confidential information.
This move became public following a government memo dated December was disclosed, indicating that President Emmerson Mnangagwa believed the arrangement was "unbalanced".
An official spokesman has since stated that the US was requesting genetic material for scientific study and profit while was unwilling to guarantee the benefits from future medical innovations.
"We are forced to start the challenging and unfortunate process of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had provided over $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has appealed for continued talks to find a deal suitable to all parties so the country's critical HIV treatment initiative can proceed.
Broader Implications
This development comes after a similar case in Kenya, where a court blocked a related health funding agreement after legal challenges were filed about the security of citizens' health data.
Since returning to office last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
USAID had overseen aid for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing direct bilateral agreements to enhance openness and responsibility.
Based on reports, Sixteen African countries have to date agreed to these new agreements, representing more than $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving HIV treatment via US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to provide its genetic material and health information indefinitely, without any equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might be developed from that provided information," his statement read.
"Put simply, our country would supply the raw materials for scientific discovery without any assurance that the resulting innovations would be available to our citizens if a new health crisis emerge."
National Interest and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its push of one-on-one health agreements were upending frameworks already established via the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to deal with potential pandemics.
"This system is designed to guarantee that when a nation contributes its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," he added.
"We encourage further discussions with our American counterparts on how future collaboration might be arranged in a way that respects the independence and dignity of both nations."
Health Experts Reaction
A leading public health body expressed it understood the official position, but suggested that talks must proceed given that a large portion of the country's HIV programmes depended on international support.
"If specific concerns exist, such as those relating to information security or implementation frameworks, these can often be addressed through detailed discussion and mutually agreed protections," the group commented.
The halted deal highlights the complex debate between accepting crucial foreign assistance and safeguarding a country's data in an increasingly interconnected world.